Last reviewed 2026-04-20 · How we verify

Buphenin (buphenine)

Buphenin (generic name: buphenine) is a buphenine drug. It is currently in unknown development for Disorder of blood vessel, Inner Ear Disturbance.

Buphenine works by stimulating the alpha-1 adrenergic receptors, which helps to constrict blood vessels and improve blood flow.

Buphenine is a small molecule drug that targets the adrenergic receptor alpha-1. It is used to treat disorders of blood vessels and inner ear disturbances. The commercial status of buphenine is unclear, as it is not listed as a patented or off-patent drug. Buphenine's safety considerations are also unknown due to a lack of FDA approval. Further research is needed to fully understand its pharmacological properties.

At a glance

Mechanism of action

Imagine your blood vessels are like roads in your body. When buphenine stimulates the alpha-1 receptors, it's like putting up a traffic light that says 'go' to the blood flow, helping it move more efficiently through the roads. This can help improve blood flow to areas that need it, like the inner ear.

Approved indications

• Disorder of blood vessel
• Inner Ear Disturbance

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• Buphenin CI brief — competitive landscape report
• Buphenin updates RSS · CI watch RSS
• portfolio CI

Frequently asked questions about Buphenin

Related

• Drug class: All buphenine drugs
• Target: All drugs targeting Adrenergic receptor alpha-1
• Manufacturer: — full pipeline
• Therapeutic area: All drugs in Hematology
• Indication: Drugs for Disorder of blood vessel
• Indication: Drugs for Inner Ear Disturbance

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing